FDMT 4D Molecular Therapeutics Inc

USD 26.38 0.00 0
Icon

4D Molecular Therapeutics Inc (FDMT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 26.38

0.00 (0.00)%

USD 1.35B

0.32M

USD 49.34(+87.05%)

N/A

Icon

FDMT

4D Molecular Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 26.38
0.00 0
Take a Tour

4D Molecular Therapeutics Inc (FDMT) Stock Forecast

Show ratings and price targets of :
USD 49.34
(+87.05%)

Based on the 4D Molecular Therapeutics Inc stock forecast from 6 analysts, the average analyst target price for 4D Molecular Therapeutics Inc is USD 49.34 over the next 12 months. 4D Molecular Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of 4D Molecular Therapeutics Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, 4D Molecular Therapeutics Inc’s stock price was USD 26.38. 4D Molecular Therapeutics Inc’s stock price has changed by +13.46% over the past week, -7.76% over the past month and +55.73% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...